tandf: Amyloid: Table of ContentsTable of Contents for Amyloid. List of articles from both the latest and ahead of print issues.
https://www.tandfonline.com/loi/iamy20?af=R
tandf: Amyloid: Table of Contentstandfen-USAmyloidAmyloidhttps://www.tandfonline.com/cms/asset/21cded4f-69c5-4eec-bfc7-4e4765ca375b/default_cover.jpg
https://www.tandfonline.com/loi/iamy20?af=R
Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2239986?af=R
<a href="/toc/iamy20/31/1">Volume 31, Issue 1</a>, March 2024, Page 22-31<br/>. <br/>Volume 31, Issue 1, March 2024, Page 22-31<br/>. <br/>Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosisdoi:10.1080/13506129.2023.2239986Amyloid2023-08-02T11:27:15ZMaria UngerichtValeria GroazMoritz MessnerThomas SchuetzLuca BrunelliMarc-Michael ZarubaDaniela LenerEva StockerAxel BauerAlexander Stephan KroissAgnes MayrChristoph RöckenGerhard Poelzla Department of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austriab Department of Emergency Medicine, Klinik Arlesheim, Arlesheim, Switzerlandc Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austriad Department of Radiology, Medical University of Innsbruck, Innsbruck, Austriae Department of Pathology, Christian-Albrechts-University, Kiel, GermanyAmyloid31122312024-01-02T08:00:00Z2024-01-02T08:00:00Z10.1080/13506129.2023.2239986https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2239986?af=RTechnetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2235881?af=R
<a href="/toc/iamy20/31/1">Volume 31, Issue 1</a>, March 2024, Page 12-21<br/>. <br/>Volume 31, Issue 1, March 2024, Page 12-21<br/>. <br/>Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosisdoi:10.1080/13506129.2023.2235881Amyloid2023-07-24T12:44:35ZKoji TakahashiYoshiyasu HiratsukaTakaaki IwamuraDaisuke SasakiNobuhisa YamamuraSohei KitazawaMitsuharu UedaHiroe MoriokaTakafumi OkuraDaijiro EnomotoShigeki UemuraTaizo KonoTomoki SakaueShuntaro Ikedaa Department of Community Emergency Medicine, Ehime University Graduate School of Medicine, Ehime, Japanb Department of Cardiology, Yawatahama City General Hospital, Ehime, Japanc Department of Radiology, Yawatahama City General Hospital, Ehime, Japand Department of Clinical Pathology, Yawatahama City General Hospital, Ehime, Japane Department of Molecular Pathology, Ehime University Graduate School of Medicine, Ehime, Japanf Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, JapanAmyloid31112212024-01-02T08:00:00Z2024-01-02T08:00:00Z10.1080/13506129.2023.2235881https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2235881?af=RDiagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2239987?af=R
<a href="/toc/iamy20/31/1">Volume 31, Issue 1</a>, March 2024, Page 32-41<br/>. <br/>Volume 31, Issue 1, March 2024, Page 32-41<br/>. <br/>Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosisdoi:10.1080/13506129.2023.2239987Amyloid2023-07-26T01:02:35ZMaria C. Azevedo CoutinhoNuno Cortez-DiasGuilhermina CantinhoSusana GonçalvesNelson CunhaTiago RodriguesLaura SantosIsabel ConceiçãoJoão AgostinhoFausto J. Pintoa Department of Cardiology, Santa Maria University Hospital, Lisbon Academic Medical Centre and Cardiovascular Centre of the University of Lisbon, Faculty of Medicine, Lisbon, Portugalb Translational Clinical Physiology Unit, Institute of Molecular Medicine, University of Lisbon, Portugalc Institute of Nuclear Medicine, Lisbon Academic Medical Centre, University of Lisbon, Lisbon, Portugald Department of Neurosciences, Santa Maria University Hospital, Lisbon Academic Medical Centre, PortugalAmyloid31132412024-01-02T08:00:00Z2024-01-02T08:00:00Z10.1080/13506129.2023.2239987https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2239987?af=RReduction in 99mTc-DPD myocardial uptake with therapy of ATTR cardiomyopathy
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2247136?af=R
<a href="/toc/iamy20/31/1">Volume 31, Issue 1</a>, March 2024, Page 42-51<br/>. <br/>Volume 31, Issue 1, March 2024, Page 42-51<br/>. <br/>Reduction in 99mTc-DPD myocardial uptake with therapy of ATTR cardiomyopathydoi:10.1080/13506129.2023.2247136Amyloid2023-08-21T04:16:45ZRené RettlRaffaella CalabrettaFranz DucaChristina BinderChristina KronbergerRobin WillixhoferMichael PoledniczekCarolina DonàChristian NitscheDietrich BeitzkeChristian LoeweMichaela Auer-GrumbachDiana BondermanStefan KastlChristian HengstenbergRoza Badr EslamJohannes KastnerJutta Bergler-KleinMarcus HackerAndreas Kammerlandera Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austriab Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austriac Division of Cardiovascular and Interventional Radiology, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austriad Department of Orthopaedics and Trauma Surgery, Medical University of Vienna, Vienna, Austriae Division of Cardiology, Department of Internal Medicine V, Favoriten Clinic, Vienna, AustriaAmyloid31142512024-01-02T08:00:00Z2024-01-02T08:00:00Z10.1080/13506129.2023.2247136https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2247136?af=RPatient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2254451?af=R
<a href="/toc/iamy20/31/1">Volume 31, Issue 1</a>, March 2024, Page 52-61<br/>. <br/>Volume 31, Issue 1, March 2024, Page 52-61<br/>. <br/>Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY studydoi:10.1080/13506129.2023.2254451Amyloid2023-09-05T02:14:01ZAlberto AimoLucio TeresiVincenzo CastiglioneAnna Lisa PicerniMartina NiccolaiSilvia SeverinoAssunta AgazioAnna Carnevale BaragliaLaura ObiciGiovanni PalladiniLucia PontiAlessia ArgiròFrancesco CappelliFederico PerfettoMatteo SerenelliGiancarlo TrimarchiRoberto LicordariGianluca Di BellaOlena ChubuchnaFilippo QuattroneSabina NutiSabina De RosisClaudio PassinoClaudio RapezziGiampaolo MerliniMichele EmdinGiuseppe Vergaroa Interdisciplinary Center for Health Sciences, Scuola Superiore Sant’Anna, Pisa, Italyb Cardiology Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italyc Cardiology Division, University Hospital of Messina, Messina, Italyd Centro per lo Studio e la Cura delle Amiloidosi Sistemiche, Fondazione Policlinico San Matteo, Pavia, Italye Regional Amyloid Center, Azienda Ospedaliero Universitaria Careggi, Florence, Italyf Department of Internal and Experimental Medicine, University of Florence, Florence, Italyg Cardiology Centre, University of Ferrara, Italyh Management and Healthcare Laboratory, Institute of Management, Scuola Superiore Sant’Anna, Pisa, Italyi Maria Cecilia Hospital, GVM Care and Research, Cotignola (Ravenna), ItalyAmyloid31152612024-01-02T08:00:00Z2024-01-02T08:00:00Z10.1080/13506129.2023.2254451https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2254451?af=RHereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2270661?af=R
<a href="/toc/iamy20/31/1">Volume 31, Issue 1</a>, March 2024, Page 62-69<br/>. <br/>Volume 31, Issue 1, March 2024, Page 62-69<br/>. <br/>Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective studydoi:10.1080/13506129.2023.2270661Amyloid2023-10-19T11:52:29ZGuillaume FargeotAndoni Echaniz-LagunaCéline LabeyrieJuliette SvahnJean-Philippe CamdessanchéPascal CintasJean-Baptiste ChansonFlorence EsselinCéline PiedvacheCéline VerstuyftSteeve GenestetEmmeline LagrangeLaurent MagyYann PéréonSabrina SacconiAissatou SignateAleksandra Nadaj-PaklezaFrédéric TaitheKarine VialaCéline TardVianney PoinsignonCécile CauquilShahram AttarianDavid Adamsa Neurology Department, CHU de Bicêtre, AP-HP, Le-Kremlin-Bicêtre, Franceb French National Reference Center for Rare Neuropathies (NNERF), Le-Kremlin-Bicêtre, Francec Inserm U1195, Paris-Saclay University, Le-Kremlin-Bicêtre, Franced Electroneuromyography and Neuromuscular Department, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Lyon, Francee Department of Neurology, University Hospital of Saint-Etienne, Saint-Etienne, Francef Department of Neurology, AOC (Atlantique-Occitanie-Caraïbes) Reference Centre for Neuromuscular Diseases, Pierre Paul Riquet Hospital, CHU Toulouse, Toulouse, Franceg Neurology Department, CHU de Strasbourg, Strasbourg, and Neuromuscular Reference Center Nord/Est/Ile de France (NEIF), Strasbourg, Franceh Explorations Neurologiques et Centre SLA, CHU et Université de Montpellier, INSERM, Montpellier, Francei Unité de Recherche Clinique Paris-Saclay, Hôpital Bicêtre, Le Kremlin-Bicêtre, Francej Service de Génétique Moléculaire, Pharmacogénétique et Hormonologie, Centre de Ressources Biologiques Paris Saclay, AP-HP, GH Paris Saclay, Hôpital Bicêtre, Le Kremlin-Bicêtre, Francek Reference Centre for Neuromuscular Diseases AOC, University Hospital of Brest, Brest, Francel Department of Neurology, Grenoble Alpes University Hospital, Grenoble, Francem Service de Neurologie, Centre de Référence Neuropathies Périphériques Rares, NNerf, UR 20218 NeurIT, CHU de Limoges, Hôpital Dupuytren, Limoges, Francen CHU Nantes, Reference Centre for Neuromuscular Diseases AOC, Hôtel-Dieu, Filnemus, Euro-NMD, Nantes, Franceo Department of Clinical Neurosciences, Neuromuscular Diseases Centre, University Hospital of Nice (CHU), Nice, Francep Department of Neurology, CHU Martinique (University Hospital of Martinique), Fort de France, Franceq Department of Neurology, University Hospital of Clermont-Ferrand (CHU Clermont-Ferrand – Gabriel Montpied Hospital), Clermont-Ferrand, FT, Francer Neurophysiology Department, AP-HP, Sorbonne Université, Pitié-Salpêtrière Hospital, Paris, Frances Centre de référence des maladies Neuromusculaires Nord/Est/Ile-de-France, U1172, CHU de Lille, Lille, Francet Service de Génétique Moléculaire, Pharmacogénétique et Hormonologie de Bicêtre, Hôpitaux Universitaires Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Le Kremlin Bicêtre, Franceu Centre de Référence des Maladies Neuromusculaires et de la SLA, APHM, CHU Timone, Marseille, FranceAmyloid31162692024-01-02T08:00:00Z2024-01-02T08:00:00Z10.1080/13506129.2023.2270661https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2270661?af=RTreatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension study
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2232520?af=R
<a href="/toc/iamy20/31/1">Volume 31, Issue 1</a>, March 2024, Page 1-11<br/>. <br/>Volume 31, Issue 1, March 2024, Page 1-11<br/>. <br/>Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension studydoi:10.1080/13506129.2023.2232520Amyloid2023-07-20T07:02:32ZSimina TicauEmre AldincMichael PolydefkisDavid AdamsTeresa CoelhoMitsuharu UedaCecilia HaleJohn VestPaul Nioia Alnylam Pharmaceuticals, Cambridge, MA, USAb Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USAc Neurology Department, AP-HP, CHU Bicêtre, Université Paris-Saclay, Paris-Saclay, Franced Centro Hospitalar Universitário Santo António, European Reference Network – EUroNMD, Porto, Portugale Graduate School of Medical Sciences, Kumamoto University, Kumamoto, JapanAmyloid3111112024-01-02T08:00:00Z2024-01-02T08:00:00Z10.1080/13506129.2023.2232520https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2232520?af=RCorrection
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2246797?af=R
<a href="/toc/iamy20/31/1">Volume 31, Issue 1</a>, March 2024, Page iii-iii<br/>. <br/>Volume 31, Issue 1, March 2024, Page iii-iii<br/>. <br/>Correctiondoi:10.1080/13506129.2023.2246797Amyloid2023-08-11T04:03:03ZAmyloid311iiiiii2024-01-02T08:00:00Z2024-01-02T08:00:00Z10.1080/13506129.2023.2246797https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2246797?af=RIntra-familial variability of oculoleptomeningeal amyloidosis due to the ATTR I107M (c.381T > G) mutation: diagnostic challenges of a rare phenotype
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2260537?af=R
<a href="/toc/iamy20/31/1">Volume 31, Issue 1</a>, March 2024, Page 70-72<br/>. <br/>Volume 31, Issue 1, March 2024, Page 70-72<br/>. <br/>Intra-familial variability of oculoleptomeningeal amyloidosis due to the ATTR I107M (c.381T > G) mutation: diagnostic challenges of a rare phenotypedoi:10.1080/13506129.2023.2260537Amyloid2023-09-27T02:00:52ZMonica AlcantaraVera BrilDepartment of Medicine, Division of Neurology, University of Toronto, Toronto, CanadaAmyloid31170722024-01-02T08:00:00Z2024-01-02T08:00:00Z10.1080/13506129.2023.2260537https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2260537?af=RHeterogeneous worldwide access and pricing of Tafamidis
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2263620?af=R
<a href="/toc/iamy20/31/1">Volume 31, Issue 1</a>, March 2024, Page 73-75<br/>. <br/>Volume 31, Issue 1, March 2024, Page 73-75<br/>. <br/>Heterogeneous worldwide access and pricing of Tafamidisdoi:10.1080/13506129.2023.2263620Amyloid2023-10-03T12:45:24ZAbdirahman WardhereDimitrios BampatsiasNowell FinePablo Garcia-PaviaMartha GroganArnt V. KristenThibaud DamyYoshiki SekijimaMathew S. Maurera Cardiac Amyloidosis Program, Columbia University Irving Medical Center, NY, USAb Libin Cardiovascular Institute, University of Calgary, Calgary, Canadac Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, CIBERCV, and Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spaind Director, Cardiac Amyloid Clinic, Division of Circulatory Failure, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USAe Department of Cardiology, University of Heidelberg, Heidelberg, Germanyf Cardiology Department and French National Reference Centre for Cardiac Amyloidosis, GRC Amyloid Research Institute and Clinical Investigation Centre 1430 at Hôpitaux Universitaires Henri-Mondor AP-HP, and IMRB, INSERM, Université Paris Est Creteil, Créteil, Franceg Shinshu University, Matsumoto, JapanAmyloid31173752024-01-02T08:00:00Z2024-01-02T08:00:00Z10.1080/13506129.2023.2263620https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2263620?af=RInappropriate use of technetium-99m pyrophosphate scanning for the evaluation of transthyretin amyloidosis
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2267162?af=R
<a href="/toc/iamy20/31/1">Volume 31, Issue 1</a>, March 2024, Page 76-78<br/>. <br/>Volume 31, Issue 1, March 2024, Page 76-78<br/>. <br/>Inappropriate use of technetium-99m pyrophosphate scanning for the evaluation of transthyretin amyloidosisdoi:10.1080/13506129.2023.2267162Amyloid2023-10-06T12:22:24ZCrystal Lihong YanNina Thakkar RiveraJames Hoffmana Division of Internal Medicine, University of Miami Health System, Miami, FL, USAb Heart, Vascular & Thoracic Institute, Cleveland Clinic Florida, Weston, FL, USAc Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL, USAAmyloid31176782024-01-02T08:00:00Z2024-01-02T08:00:00Z10.1080/13506129.2023.2267162https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2267162?af=RThe way to a man’s heart: prostate samples for the early detection of transthyretin cardiomyopathy
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2268812?af=R
<a href="/toc/iamy20/31/1">Volume 31, Issue 1</a>, March 2024, Page 79-81<br/>. <br/>Volume 31, Issue 1, March 2024, Page 79-81<br/>. <br/>The way to a man’s heart: prostate samples for the early detection of transthyretin cardiomyopathydoi:10.1080/13506129.2023.2268812Amyloid2023-10-12T06:10:23ZLawrence ZeldinKaran WatsKathleen M. O’TooleFabrizio RemottiMathew S. Maurera Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, NY, USAb Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USAAmyloid31179812024-01-02T08:00:00Z2024-01-02T08:00:00Z10.1080/13506129.2023.2268812https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2268812?af=RAA amyloidosis in a father and daughter as complication of PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2272556?af=R
<a href="/toc/iamy20/31/1">Volume 31, Issue 1</a>, March 2024, Page 82-84<br/>. <br/>Volume 31, Issue 1, March 2024, Page 82-84<br/>. <br/>AA amyloidosis in a father and daughter as complication of PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndromedoi:10.1080/13506129.2023.2272556Amyloid2023-10-23T04:47:37ZAnne F. BrungerHans L. A. NienhuisJohan BijzetEvelien Zonneveld-HuijssoonJan S. F. SandersGeertje E. LeggerReinold O.B GansBouke P. C. Hazenberga Department of Rheumatology & Clinical Immunology, University Medical Center Groningen, The Netherlandsb Amyloidosis Center of Expertise, University Medical Center Groningen, The Netherlandsc Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlandsd Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlandse Department of Clinical Genetics, University Medical Center Groningen, Groningen, The Netherlandsf Department of Nephrology, University Medical Center Groningen, Groningen, The Netherlandsg Department of Pediatric Rheumatology, University Medical Center Groningen, Groningen, The Netherlandsh Department of Rheumatology & Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlandsi Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The NetherlandsAmyloid31182842024-01-02T08:00:00Z2024-01-02T08:00:00Z10.1080/13506129.2023.2272556https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2272556?af=RSequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2295221?af=R
. <br/>. <br/>Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myelomadoi:10.1080/13506129.2023.2295221Amyloid2024-01-11T02:46:11ZSarah SchreinerNatalie BerghausAlexandra M. PoosMarc S. RaabBritta BesemerRoland FenkHartmut GoldschmidtElias K. MaiCarsten Müller-TidowNiels WeinholdUte HegenbartStefanie HuhnStefan O. Schönlanda Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germanyb Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, Germanyc Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, National Centre for Tumor Diseases (NCT), Heidelberg, Germanyd Department of Internal Medicine II, Tübingen University Hospital, Tübingen, Germanye Department of Hematology, Oncology, and Clinical Immunology, Düsseldorf University Hospital, Düsseldorf, Germanyf Medical Department V, Heidelberg University Hospital, Heidelberg, GermanyAmyloid1910.1080/13506129.2023.2295221https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2295221?af=RSerum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice
https://www.tandfonline.com/doi/full/10.1080/13506129.2024.2313218?af=R
. <br/>. <br/>Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practicedoi:10.1080/13506129.2024.2313218Amyloid2024-02-13T09:52:46ZAntonia S. CarrollYousuf RazviLuke O’DonnellElena VelevaAmanda HeslegraveHenrik ZetterbergSteve VucicMatthew C. KiernanAlexander M. RossorJulian D. GillmoreMary M. Reillya Brain and Mind Centre, Faculty of Medicine and Health, Translational Research Collective University of Sydney and Department of Neurology, Royal Prince Alfred Hospital, Sydney, Australiab Centre for Neuromuscular disease, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UKc National Amyloidosis Centre, UCL Division of Medicine, Royal Free Hospital, London, UKd UK Dementia Research Institute at UCL, London, UKe Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UKf Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Swedeng Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Swedenh Hong Kong Center for Neurodegenerative Diseases, Hong Kong, Chinai WI Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USAj Brain and Nerve Research Centre, Concord Hospital, University of Sydney, Sydney, AustraliaAmyloid11010.1080/13506129.2024.2313218https://www.tandfonline.com/doi/full/10.1080/13506129.2024.2313218?af=RMass spectrometry-based proteomic analysis of proteins adsorbed by hexadecyl-immobilized cellulose bead column for the treatment of dialysis-related amyloidosis
https://www.tandfonline.com/doi/full/10.1080/13506129.2024.2315148?af=R
. <br/>. <br/>Mass spectrometry-based proteomic analysis of proteins adsorbed by hexadecyl-immobilized cellulose bead column for the treatment of dialysis-related amyloidosisdoi:10.1080/13506129.2024.2315148Amyloid2024-02-12T05:50:02ZSuguru YamamotoKeiko YamamotoYoshitoshi HiraoKeiichi YamaguchiKichitaro NakajimaMami SatoMiho KawachiMio DomonKei GotoKentaro OmoriNoriaki IinoHisaki ShimadaRyuzi AoyagiIsei EiShin GotoYuji GotoFumitake GejyoTadashi YamamotoIchiei Naritaa Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japanb Biofluid Biomarker Center, Niigata University, Niigata, Japanc Instrumental Analysis Section, Okinawa Institute of Science and Technology, Onna, Japand Graduate School of Engineering, Osaka University, Osaka, Japane Sakelogy Center, Niigata University, Niigata, Japanf Division of Clinical Chemistry, Niigata University Graduate School of Health Sciences, Niigata, Japang Division of Nephrology, Agano Municipal Hospital, Niigata, Japanh Omori Medical Clinic, Niigata, Japani Division of Nephrology, Uonuma Kikan Hospital, Niigata, Japanj Kidney Center of Shinraku-en Hospital, Niigata, Japank Department of Nephrology, Tachikawa General Hospital, Niigata, Japanl Santo-Second Clinic, Niigata, Japanm Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japann Department of Clinical Laboratory, Shinrakuen Hospital, Niigata, JapanAmyloid11110.1080/13506129.2024.2315148https://www.tandfonline.com/doi/full/10.1080/13506129.2024.2315148?af=RGait abnormalities in older adults with transthyretin cardiac amyloidosis
https://www.tandfonline.com/doi/full/10.1080/13506129.2024.2319133?af=R
. <br/>. <br/>Gait abnormalities in older adults with transthyretin cardiac amyloidosisdoi:10.1080/13506129.2024.2319133Amyloid2024-03-04T06:30:01ZFitsum E. PetrosAlfonsina Mirabal SantosAdedeji AdeniyiSergio TeruyaJeffeny De Los SantosMathew S. MaurerSunil K. Agrawala Department of Mechanical Engineering, Columbia University, New York, NY, USAb Department of Medicine, Division of Cardiology, Columbia University, New York, NY, USAc Vagelos College of Physicians & Surgeons, Irvine Medical Center, Columbia University, New York, NY, USAd Rehabilitation and Regenerative Medicine, Columbia University, New York, NY, USAAmyloid1810.1080/13506129.2024.2319133https://www.tandfonline.com/doi/full/10.1080/13506129.2024.2319133?af=RCirculating transthyretin and retinol binding protein 4 levels among middle-age V122I TTR carriers in the general population
https://www.tandfonline.com/doi/full/10.1080/13506129.2024.2322479?af=R
. <br/>. <br/>Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I TTR carriers in the general populationdoi:10.1080/13506129.2024.2322479Amyloid2024-03-06T12:44:49ZNicholas S. HendrenJames A. De LemosJarett D. BerryJulia KozlitinaLorena SaelicesAlan X. JiZhili ShaoChia-Feng LiuSonia GargMaryjane A. FarrMark H. DraznerW. H. Wilson TangJustin L. Grodina Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USAb Parkland Health System, Dallas, TX, USAc Department of Internal Medicine, University of Texas at Tyler, Tyler, TX, USAd Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USAe Department of Biophysics, Center for Alzheimer’s and Neurodegenerative Diseases, University of Texas Southwestern Medical Center, Dallas, TX, USAf Eidos Therapeutics, a BridgeBio Company, Palo Alto, CA, USAg Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USAh Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USAAmyloid1810.1080/13506129.2024.2322479https://www.tandfonline.com/doi/full/10.1080/13506129.2024.2322479?af=RLongitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis
https://www.tandfonline.com/doi/full/10.1080/13506129.2024.2327342?af=R
. <br/>. <br/>Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosisdoi:10.1080/13506129.2024.2327342Amyloid2024-03-13T08:07:24ZMilou BerendsAnne F. BrungerJohan BijzetBart-Jan KroesenGea DrostFiete LangeCharlotte E. TeunissenSjors in ‘t VeldAlexander FJE VranckenReinold O. B. GansBouke P. C. HazenbergPaul A. van der ZwaagHans L. A. Nienhuisa Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlandsb Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlandsc Department of Rheumatology & Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlandsd Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlandse Department of Neurology, University Medical Center Groningen, Groningen, The Netherlandsf Department of Laboratory Medicine, Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlandsg Department of Neurology, University Medical Center Utrecht, Utrecht, The Netherlandsh Department of Medical Genetics, University Medical Center Groningen, Groningen, The NetherlandsAmyloid11010.1080/13506129.2024.2327342https://www.tandfonline.com/doi/full/10.1080/13506129.2024.2327342?af=RLongitudinal PET/CT imaging with iodine (124I) evuzamitide reveals organ response to plasma cell immunotherapy in a patient with AL amyloidosis
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2286427?af=R
. <br/>. <br/>Longitudinal PET/CT imaging with iodine (124I) evuzamitide reveals organ response to plasma cell immunotherapy in a patient with AL amyloidosisdoi:10.1080/13506129.2023.2286427Amyloid2023-11-22T10:43:33ZRonald LandsEmily B. MartinDustin PowellAlan StuckeyBryan WhittleSpencer GuthrieRenju RajStephen J. KennelJonathan S. Walla University of TN Graduate School of Medicine, Knoxville, TN, USAb Hendersonville Radiologic Consultants, Hendersonville, NC, USAc University of Tennessee Medical Center, Knoxville, TN, USAd Attralus, Inc, San Francisco, CA, USAAmyloid1210.1080/13506129.2023.2286427https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2286427?af=RLongitudinal evolution of ventricular function and cardiac magnetic resonance imaging tissue characteristics in tafamidis-treated transthyretin amyloid cardiomyopathy
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2284108?af=R
. <br/>. <br/>Longitudinal evolution of ventricular function and cardiac magnetic resonance imaging tissue characteristics in tafamidis-treated transthyretin amyloid cardiomyopathydoi:10.1080/13506129.2023.2284108Amyloid2023-12-09T10:52:53ZStephan DobnerBenedikt BernhardMonika WieserAndreas WahlAnselm W. StarkValentin KöchliGiancarlo SpanoMartina Boscolo BertoCaroline JohnerElena ElchinovaGiulin TannerYasaman SafarkhanloStefan StorteckyJonathan SchützeLukas Hunziker MunschChristoph GräniDepartment of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandAmyloid1310.1080/13506129.2023.2284108https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2284108?af=RDual AApoAIV amyloidosis and ATTR amyloidosis arising in the same patient: a report of three cases
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2292949?af=R
. <br/>. <br/>Dual AApoAIV amyloidosis and ATTR amyloidosis arising in the same patient: a report of three casesdoi:10.1080/13506129.2023.2292949Amyloid2023-12-15T02:11:33ZJoanna C. DallandLinda N. DaoSurendra DasariJason D. TheisApril ChiuKaren L. RechMatthew T. HowardMartha GroganCatherine HagenMelanie C. BoisEllen D. McPhaila Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USAb Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USAc Department of Medicine, Mayo Clinic, Rochester, MN, USAAmyloid1310.1080/13506129.2023.2292949https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2292949?af=RSymptomatic SARS-CoV2 infection associated with high mortality in AA amyloidosis
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2294434?af=R
. <br/>. <br/>Symptomatic SARS-CoV2 infection associated with high mortality in AA amyloidosisdoi:10.1080/13506129.2023.2294434Amyloid2023-12-21T01:39:15ZRim BourguibaAlexandre TerréLea SaveyEric OziolThomas HanslikJean-Emmanuel KahnRaphael BorieAlexandre CezDavid BuobGilles GrateauJean-Jacques BoffaSophie Georgin-Laviallea Internal Medicine Department, Tenon Hospital, AP-HP, Paris, Franceb National French Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Paris, Francec Internal Medicine Department, Béziers Hospital, Béziers, Franced Internal Medicine Department, Ambroise Paré Hospital, APHP, Paris, Francee Pneumology Department, Bichat Hospital, AP-HP, Paris, Francef Nephrology Department, Tenon hospital, AP-HP, Paris, Franceg Anatomopathology Department, Tenon Hospital, AP-HP, Paris, Franceh Sorbonne University, Paris, FranceAmyloid1310.1080/13506129.2023.2294434https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2294434?af=RIdentification of calcitonin receptor-stimulating peptide 1-derived amyloid in a feline C-cell carcinoma
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2282361?af=R
. <br/>. <br/>Identification of calcitonin receptor-stimulating peptide 1-derived amyloid in a feline C-cell carcinomadoi:10.1080/13506129.2023.2282361Amyloid2023-11-20T05:11:11ZTomoaki MurakamiNatsumi KobayashiSusumu IwaideYoshiyuki ItohMiki HisadaTakeshi IzawaMitsuru Kuwamuraa Cooperative Department of Veterinary Medicine, Tokyo University of Agriculture and Technology, Tokyo, Japanb Smart-Core-Facility Promotion Organization, Tokyo University of Agriculture and Technology, Tokyo, Japanc Laboratory of Veterinary Pathology, Osaka Metropolitan University, Osaka, JapanAmyloid1310.1080/13506129.2023.2282361https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2282361?af=RNeurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis
https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2289340?af=R
. <br/>. <br/>Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosisdoi:10.1080/13506129.2023.2289340Amyloid2023-12-11T08:39:49ZK. H. Vincent LauTatiana ProkaevaLuke ZhengGheorghe DorosMichelle C. KakuBrian SpencerJohn BerkVaishali SanchorawalaAmyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA, USAAmyloid1310.1080/13506129.2023.2289340https://www.tandfonline.com/doi/full/10.1080/13506129.2023.2289340?af=RPossible transmission of leukocyte chemotactic factor 2 amyloidosis after interpopulational liver transplantation
https://www.tandfonline.com/doi/full/10.1080/13506129.2024.2322480?af=R
. <br/>. <br/>Possible transmission of leukocyte chemotactic factor 2 amyloidosis after interpopulational liver transplantationdoi:10.1080/13506129.2024.2322480Amyloid2024-03-06T05:51:37ZYuji SuzukiMasayoshi TasakiKeisuke KakisakaMasao NishiyaToshiya NomuraMitsuki NakaoErika SugawaraYasuhiro TakikawaMitsuharu Uedaa Division of Allergy and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japanb Institute for Biomedical Sciences Molecular Pathophysiology, Iwate Medical University, Yahaba, Japanc Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japand Department of Biomedical Laboratory Sciences, Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japane Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japanf Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine, Yahaba, Japang Independent Scholar, Morioka, JapanAmyloid1310.1080/13506129.2024.2322480https://www.tandfonline.com/doi/full/10.1080/13506129.2024.2322480?af=R